D115 Unit 3 Videos: Bacterial Meningitis & Neurologic System Alterations

Student Name

Western Governors University

D115 Advanced Pathophysiology for the Advanced Practice Nurse

Prof. Name

Date

D115 Unit 3 Videos: Bacterial Meningitis & Neurologic System Alterations

Bacterial Meningitis

What Is Bacterial Meningitis?

Bacterial meningitis is a serious and potentially life-threatening infection characterized by inflammation of the meninges, specifically the pia mater and arachnoid mater that surround the brain and spinal cord. Although meningitis may arise from viral, fungal, parasitic, toxic, or noninfectious causes, bacterial forms are associated with higher morbidity and mortality due to rapid disease progression and systemic complications.

Which Pathogens Are Most Common?

Several bacterial organisms are responsible for the majority of meningitis cases worldwide. The most frequently implicated pathogens are summarized below.

Pathogen	Clinical Significance
Neisseria meningitidis	Major cause of outbreaks, particularly in adolescents and young adults
Streptococcus pneumoniae	Common in adults; associated with antibiotic resistance and severe outcomes

Who Is at Risk?

Certain populations are more susceptible to bacterial meningitis due to immature or compromised immune defenses. Infants under one year of age, adolescents, and adults over 40 years face the highest risk. Transmission is more common in crowded environments such as college dormitories, military barracks, and areas within Sub-Saharan Africa where endemic outbreaks occur.

What Are the Predisposing Factors?

Risk increases when individuals have underlying conditions that compromise immune function or create pathways for bacterial invasion. These include chronic ear or sinus infections, pneumonia, immunosuppressive conditions, post-splenectomy status, and sickle cell disease, which significantly elevates the risk for pneumococcal meningitis.

How Is Bacterial Meningitis Transmitted?

Transmission occurs primarily through respiratory droplets and direct contact with saliva. Activities such as coughing, sneezing, kissing, or sharing eating utensils facilitate spread. Importantly, asymptomatic carriers may unknowingly transmit the bacteria to others.

What Happens in the Body? (Pathophysiology)

The disease process begins when bacteria enter the bloodstream or respiratory tract and cross the blood-brain barrier. Once in the cerebrospinal fluid (CSF), the organisms multiply rapidly due to limited immune surveillance. The resulting inflammatory response increases vascular permeability, leading to cerebral edema, impaired CSF circulation, and elevated intracranial pressure. Without prompt treatment, this cascade may progress to brainstem herniation and death.

What Are the Clinical Features?

Clinical manifestations vary but typically include systemic, meningeal, and neurologic signs.

Symptom Category	Key Features
Systemic	Fever, chills, tachycardia
Meningeal	Severe headache, photophobia, neck stiffness, positive Kernig and Brudzinski signs
Neurologic	Altered consciousness, seizures, focal deficits, vomiting, papilledema, petechiae, bulging fontanel in infants

How Is Bacterial Meningitis Diagnosed?

Diagnosis is confirmed through lumbar puncture demonstrating elevated white blood cells in CSF, increased protein, and decreased glucose levels. Blood cultures are essential for identifying the causative organism and guiding antibiotic selection.

What Is the Treatment?

Immediate initiation of empiric intravenous antibiotics is critical and should not be delayed for diagnostic confirmation. Therapy is later tailored based on culture results. Adjunctive corticosteroid therapy, such as dexamethasone, is recommended in suspected pneumococcal meningitis to reduce neurologic complications. Supportive care includes fluid management, oxygen therapy, and seizure control.

What Complications Can Occur?

Severe complications include septic shock, disseminated intravascular coagulation (DIC), purpura fulminans, multi-organ dysfunction, permanent neurologic deficits, and death.

How Can Bacterial Meningitis Be Prevented?

Prevention relies heavily on routine immunization programs targeting Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type B. Chemoprophylaxis may be indicated for close contacts during outbreaks.

Guillain-Barré Syndrome (GBS)

What Is Guillain-Barré Syndrome?

Guillain-Barré syndrome is an acute autoimmune disorder affecting the peripheral nervous system, characterized by rapid demyelination and progressive ascending muscle weakness that can result in respiratory failure.

What Causes Guillain-Barré Syndrome?

GBS commonly follows viral or bacterial infections that trigger an abnormal immune response. Documented triggers include Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, influenza, Mycoplasma pneumoniae, Zika virus, recent surgery, or vaccination.

What Is the Underlying Mechanism?

Through molecular mimicry, antibodies generated against infectious agents cross-react with peripheral nerve myelin or axons. This immune-mediated injury disrupts nerve conduction and leads to muscle weakness and sensory deficits.

What Are the Subtypes of GBS?

Subtype	Description
Acute inflammatory demyelinating polyneuropathy	Most common form; primarily demyelinating
Acute motor axonal neuropathy	Selective motor axon involvement
Acute motor-sensory axonal neuropathy	Affects both sensory and motor axons
Miller Fisher syndrome	Rare variant with ataxia, ophthalmoplegia, and areflexia

What Symptoms Does GBS Present With?

Patients typically develop symmetric ascending flaccid paralysis, paresthesia, muscle weakness, diminished reflexes, and autonomic instability. Respiratory muscle involvement may occur within two weeks, requiring mechanical ventilation.

How Is GBS Diagnosed?

Diagnosis is clinical and requires progressive weakness in at least two limbs, decreased or absent reflexes, and symptom progression over less than four weeks.

What Treatment Options Exist?

Management includes intravenous immunoglobulin (IVIG) or plasmapheresis to reduce immune-mediated nerve damage. Early respiratory monitoring and intensive rehabilitation are essential components of care.

What Is the Prognosis?

Most patients recover over weeks to months, although complete recovery may take up to two years. Approximately 30% experience persistent weakness or fatigue.

Multiple Sclerosis (MS)

What Defines Multiple Sclerosis?

Multiple sclerosis is a chronic, immune-mediated disease characterized by demyelination and neurodegeneration within the central nervous system.

What Is the Pathophysiology?

Activated T-cells breach the blood-brain barrier and release inflammatory cytokines that damage oligodendrocytes. This results in focal demyelinated plaques visible on MRI. Remyelination occurs early but diminishes as the disease progresses.

Who Is at Risk?

Risk factors include female sex, HLA-DR2 genetic susceptibility, vitamin D deficiency, and residence in regions farther from the equator.

What Types of MS Exist?

Type	Description
Relapsing-remitting	Episodes of relapse followed by remission
Secondary progressive	Gradual worsening after initial relapsing course
Primary progressive	Steady decline from onset
Progressive-relapsing	Progressive disease with acute relapses

What Are Common Symptoms?

Symptoms typically begin between ages 20 and 40 and include motor weakness, spasticity, tremor, sensory disturbances, visual impairment, speech difficulties, autonomic dysfunction, and cognitive decline. Charcot’s triad—dysarthria, nystagmus, and intention tremor—is characteristic.

How Is MS Diagnosed?

Diagnosis is based on MRI findings of CNS plaques, CSF oligoclonal bands, visual evoked potentials, and evidence of lesions separated in time and space.

What Treatments Are Available?

Acute relapses are treated with corticosteroids, IVIG, or plasmapheresis. Disease-modifying therapies include interferon-beta and immunosuppressive agents. Rehabilitation focuses on symptom control and functional independence.

Myasthenia Gravis

What Is Myasthenia Gravis?

Myasthenia gravis is a chronic autoimmune disorder causing fluctuating skeletal muscle weakness due to impaired neuromuscular transmission.

What Causes Myasthenia Gravis?

Autoantibodies destroy acetylcholine receptors at the neuromuscular junction, preventing effective nerve-to-muscle signaling.

What Symptoms Are Characteristic?

Common manifestations include ptosis, diplopia, facial muscle weakness, dysphagia, dysarthria, limb and neck weakness, with symptoms worsening with activity and improving with rest.

How Is Diagnosis Made?

Diagnostic Tool	Purpose
Acetylcholine receptor antibodies	Detect autoimmune antibodies
Anti-MuSK antibodies	Alternative antibody testing
Electromyography	Evaluate neuromuscular transmission
Edrophonium test	Temporary symptom improvement
CT/MRI	Identify thymoma

What Are Treatment Approaches?

Treatment includes anticholinesterase agents, immunosuppressive therapy, thymectomy when indicated, and IVIG or plasmapheresis during severe exacerbations.

Diabetes Mellitus

Overview

Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia resulting from insufficient insulin production, impaired insulin action, or both.

How Is Blood Glucose Regulated?

Insulin lowers blood glucose by promoting cellular uptake, while glucagon raises glucose levels. Both hormones are secreted by pancreatic islet cells.

Type 1 Diabetes Mellitus

Type 1 diabetes results from autoimmune destruction of pancreatic β-cells, leading to absolute insulin deficiency. It is associated with HLA-DR3 and DR4 genotypes and presents with polyuria, polydipsia, polyphagia, and glycosuria. Diabetic ketoacidosis is a life-threatening complication, and lifelong insulin therapy is required.

Type 2 Diabetes Mellitus

Type 2 diabetes is characterized by insulin resistance and relative insulin deficiency. It is strongly associated with obesity and genetic predisposition. Complications include hyperosmolar hyperglycemic state. Management focuses on lifestyle modification, oral antidiabetic agents such as metformin, and insulin when necessary.

How Is Diabetes Diagnosed? (WHO Criteria)

Test	Diagnostic Threshold
Fasting plasma glucose	≥126 mg/dL
Random plasma glucose	≥200 mg/dL
OGTT (2-hour)	≥200 mg/dL
HbA1c	≥6.5%

Hyperparathyroidism

What Is Hyperparathyroidism?

Hyperparathyroidism is a disorder characterized by excessive secretion of parathyroid hormone, resulting in hypercalcemia and bone metabolism abnormalities.

What Are the Types?

Type	Cause
Primary	Parathyroid adenoma or hyperplasia
Secondary	Chronic kidney disease or vitamin D deficiency
Tertiary	Autonomous PTH secretion after prolonged secondary disease

What Symptoms Occur?

Patients may present with kidney stones, bone pain, fractures, osteoporosis, gastrointestinal disturbances, neuropsychiatric symptoms, polyuria, and polydipsia.

How Is It Managed?

Primary hyperparathyroidism is treated surgically. Secondary forms are managed with vitamin D supplementation, phosphate control, and calcimimetic agents such as cinacalcet.

Thyroid Disorders

Hyperthyroidism (Graves’ Disease)

Graves’ disease results from autoimmune stimulation of thyroid-stimulating hormone receptors. Symptoms include weight loss, tremor, anxiety, and heat intolerance. Laboratory findings show low TSH and elevated T3/T4. Management includes antithyroid medications, beta-blockers, and surgery. Thyroid storm represents a medical emergency requiring intensive care.

Hypothyroidism (Hashimoto’s Thyroiditis)

Hashimoto’s thyroiditis is an autoimmune disorder causing thyroid gland destruction. Patients present with fatigue, weight gain, and cold intolerance. Treatment involves lifelong levothyroxine replacement.

Otitis Media

What Is Otitis Media?

Otitis media is inflammation of the middle ear and is most commonly seen in pediatric populations.

How Is It Diagnosed?

Diagnosis is based on reduced tympanic membrane mobility, confirmed using pneumatic otoscopy or tympanometry.

What Is the Treatment?

High-dose amoxicillin is the first-line therapy. Watchful waiting may be appropriate in mild, uncomplicated cases.

Mental Health Disorders

Disorder	Definition	Treatment
Depression	Depressed mood or loss of interest for ≥2 weeks	SSRIs, psychotherapy
Generalized Anxiety Disorder	Excessive worry lasting ≥6 months	CBT, SSRIs/SNRIs
Schizophrenia	Psychotic disorder with positive and negative symptoms	Antipsychotics, psychosocial therapy

References

American Diabetes Association. (2023). Classification and diagnosis of diabetes. Diabetes Care, 46(Supplement 1), S19–S33. https://doi.org/10.2337/dc23-S002

Harrison, T. R. (2018). Harrison’s principles of internal medicine (20th ed.). McGraw-Hill Education.

Jameson, J. L., Fauci, A. S., Kasper, D. L., Hauser, S. L., Longo, D. L., & Loscalzo, J. (2018). Harrison’s manual of medicine (19th ed.). McGraw-Hill Education.

Kumar, V., Abbas, A. K., & Aster, J. C. (2020). Robbins basic pathology (10th ed.). Elsevier.